The FDA finds that a heart stent developed by Stryker (SYK) might not be worth the additional...

|About: Stryker Corporation (SYK)|By:, SA News Editor

The FDA finds that a heart stent developed by Stryker (SYK) might not be worth the additional risks for patients because it offers no added benefits over existing drugs used to help prevent strokes. (report)